The FDA has authorized HyQvia (immune globulin infusion 10% with recombinant human hyaluronidase) as a maintenance treatment to prevent the relapse of neuromuscular disability and impairment in adult patients with CIDP
321 (6) KGF Keratinocyte Growth Factor (KGF) enhanced physiological outcomes and markers of alveolar epithelial cell function in various animal models of ARDS/ALI
If you notice irritation or inflammation around the injection site, dont worry
Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, et al
GHK-Cu meaningfully helps with follicle size, scalp health, and hair density for many users, but the magnitude of effect in well-designed trials has not approached what finasteride delivers for DHT-driven miniaturization
Agios Pharmaceuticals) Sickle Cell Disease (PDUFA: Dec 7) 7